Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00648635 · ClinicalTrials.gov registry record
Relationship Between Quality of Life, Treatment Modalities, and Patient Treatment/Outcome Expectations
A clinical trial of Rectal Cancer, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- 116
- Enrollment target
- 1
- Study location
NCT00648635: Active study of Rectal Cancer, sponsored by M.D. Anderson Cancer Center.
NCT00648635 is a study of Rectal Cancer that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 116 participants, below the 3,165-participant average among 70 other Rectal Cancer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00648635, a study of Rectal Cancer, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 116 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to learn how the treatment given to patients with recurrent rectal cancer affects their well being and quality of life.
Primary Outcome
Primary endpoint of QOL assessed using EORTC QLQ-CR29 survey form. Change of QOL defined as the difference between the baseline and the QOL at 6-month intervals.
Conditions Studied
Interventions
- BEHAVIORAL Questionnaire
Study Locations (1)
Texas
- University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2008-03-12 |
| Est. Completion | 2027-09-30 |
What the registry record for NCT00648635 still lists
NCT00648635 is an observational study that tracks outcomes without assigning an intervention. The registered 116 participants enrollment target is mid-sized for trials with a published cap, below the 3,165-participant average among 70 other Rectal Cancer trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Rectal Cancer appearing as the primary indexed condition, and to 1 intervention - of which Questionnaire is the first listed.
NCT00648635 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00648635 about?
NCT00648635 is a clinical study titled "Relationship Between Quality of Life, Treatment Modalities, and Patient Treatment/Outcome Expectations". The goal of this study is to learn how the treatment given to patients with recurrent rectal cancer affects their well being and quality of life.
What is the current status of trial NCT00648635?
This trial is currently active not recruiting. The enrollment target is 116 participants. The study started on 2008-03-12. Estimated completion is 2027-09-30.
What conditions does trial NCT00648635 study?
This clinical trial studies the following conditions: Rectal Cancer.
What interventions are being tested in trial NCT00648635?
The interventions under investigation include: Questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT00648635?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00648635 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00648635's enrollment target sits among peer trials
116 23rd of 70 higher than 48 of 70 other Rectal Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Rectal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
RECRUITING · Phase 1
-
Exosomes in Rectal Cancer
RECRUITING
-
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
RECRUITING · Phase 2
-
A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer.
RECRUITING · Phase 2
-
An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer
RECRUITING · NA
-
Ultrasound and Photoacoustic Imaging for Enhanced Differential Diagnosis of Rectal Cancer
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03014687 · 116 participants · Phase 4
Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions
- NCT03214562 · 116 participants · Phase 1
Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia
- NCT03847467 · 116 participants · Phase 1
Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy
- NCT04222413 · 116 participants · Phase 1
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy